We recently showed that A 2A adenosine receptor activation by endogenous adenosine contributes to interleukin-10 (IL-10) production in polymicrobial sepsis. Here we investigated the molecular mechanisms underpinning this interaction between adenosine receptor signaling and infection by exposing macrophages to Escherichia coli. We demonstrated using receptor knockout mice that A 2A receptor activation is critically required for the stimulatory effect of adenosine on IL-10 production by E coli-challenged macrophages, whereas A 2B receptors have 
Introduction
The innate immune system is responsible for identifying infectious pathogens and eliciting specific immune responses to eliminate the pathogens. Pathogen recognition can be mediated by a set of pattern recognition receptors. One class of pattern recognition receptors involves the Toll-like receptors (TLRs), which consist of a family of transmembrane molecules found in a broad range of organisms from Drosophila to higher mammals. [1] [2] [3] [4] [5] TLR4 was first recognized as the receptor mediating the macrophage stimulatory effect of endotoxins (lipopolysaccharide, LPS) of Gram-negative bacteria, such as Escherichia coli. Other Gram-negative bacterial components can also induce macrophage activation via various other pattern recognition receptors, which include TLR2 (lipopeptide receptor), TLR5 (flagellin receptor), and TLR9 (CpG DNA receptor), as well as nucleotide-binding oligomerization domain (nucleotide-binding oligomerization domain 1, peptidoglycan receptor) and nucleotide-binding oligomerization domain 2 (muramyl dipeptide receptor). 4, 5 Lipoteichoid acid, a component of Grampositive bacteria, activates cellular responses via TLR2. 4, 5 The engagement of pattern recognition receptors by microbial components triggers the activation of signaling cascades leading to the induction of genes involved in antimicrobial host defense such as cytokines and chemokines. [6] [7] [8] Myeloid differentiation factor 88 (MyD88) has been shown to be a critical adaptor protein linking TLRs to several downstream intracellular pathways. 4, 5 Many of the activating signals originating from TLRs and MyD88 converge on tumor necrosis factor receptor-associated factor 6 (TRAF6), which transduces the signals toward the nuclear factor-B system and mitogen-activated protein kinases (MAPKs), resulting in induction of genes involved in pro-inflammatory responses. 4, 5 Much less is known about the regulation of anti-inflammatory cytokines and their genes, the most prominent of which is IL-10. 9,10 IL-10 is an inducible gene and several transcriptional factors have been implicated in its regulation, which include Sp1, [11] [12] [13] Sp3, 12 C/EBP␦ and C/EBP␤, 14 STAT3, 15 and c-Maf. 16 IL-10 gene expression also requires transient remodeling of the IL-10 promoter that occurs as a result of MAPK activation. 17 In addition, we and others 18, 19 have recently shown that IL-10 production is also regulated at various posttranscriptional levels, including alterations in mRNA stability and translation efficacy.
Adenosine, an endogenous purine nucleoside, is a biologically active extracellular signaling molecule that is formed at sites of metabolic stress associated with hypoxia, ischemia, trauma, or inflammation. Adenosine mediates its effects via engaging A 1 , A 2A , A 2B , and A 3 adenosine receptors, 20 which are all expressed abundantly on monocytes and macrophages. 21 Stimulation of adenosine receptors has been shown to convert the phenotype of TLR4 (LPS)-stimulated macrophages from a pro-inflammatory to an anti-inflammatory one. [21] [22] [23] [24] [25] [26] [27] Most notably, adenosine receptor activation has been documented to upregulate the TLR4-induced production of IL-10. [28] [29] [30] In addition to TLR4-stimulated macrophages, adenosine enhanced IL-10 production by tumor necrosis factor-␣-stimulated or hydrogen peroxide-stimulated human monocytes. 31 We recently demonstrated that genetic inactivation of the A 2A receptor almost abolished IL-10 production in the cecal ligation and puncture model of murine polymicrobial sepsis, which suggested that A 2A receptor activation is required for IL-10 production after bacterial stimuli. 32 Because during sepsis the host is challenged with whole bacteria that possess multiple components capable of triggering IL-10 production via various pattern recognition receptors, the relevance of findings with limited stimuli such as LPS, tumor necrosis factor-␣, or hydrogen peroxide to bacterial infections is not clear. In addition, the cellular mechanisms by which A 2A receptor activation regulates IL-10 production in response to clinically relevant stimuli, such as whole bacteria, are unknown. Here we show that A 2A receptor activation and bacteria synergistically induce IL-10 production by macrophages, a process that is critically dependent on the transcription factor C/EBP␤.
Materials and methods

Drugs and reagents
Adenosine, the selective A 1 receptor agonist CCPA (2- . The p38 pathway inhibitor SB203580 and p42/44 pathway inhibitor PD98059 were purchased from Calbiochem (San Diego, CA). Stock solutions of the various agonists and protein kinase inhibitors were prepared using dimethylsulphoxide. Lipoteichoic acid prepared from Staphylococcus aureus was from Invitrogen (Carlsbad, CA).
Experimental animals and cell cultures
Male CD-1 mice were purchased from Charles River Laboratories (Wilmington, MA). A 2A receptor knockout (KO) mice and their wild-type (WT) littermates 32, 33 and MyD88 KO and WT mice on the C57Bl/6J background, 34 kindly provided by Dr Shizuo Akira (Osaka University, Osaka, Japan) were bred in a specific pathogen-free facility using founder heterozygous male and female mice. Male TLR4 KO (C57BL/10ScNJ) and WT (C57BL/10ScSnJ) littermates mice were obtained from the Jackson Laboratory (Bar Harbor, ME). A 2B receptor KO mice were acquired from Deltagen Inc. (San Mateo, CA). Mice were backcrossed 10 generations onto a C57Blk/6J background. A 2B -null mice were generated by the insertion of a lacZNeo cassette into exon 1 of an A 2B receptor WT allele ( Figure S1A , on the Blood website via the Supplemental Data link at the top of the online article, shows genotyping details). Measurement of A 2B receptor transcripts in large intestine and bladder revealed an absence of A 2B receptor transcripts in mice homozygous for the targeted A 2B receptor allele ( Figure S1B) . A normal Mendelian ratio of inheritance of the mutant allele was seen after heterozygous matings. A 2B receptor KO mice survive a normal lifespan with no obvious external defects and reproduce normally (data not shown). All mice were maintained in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals, and the experiments were approved by the New Jersey Medical School Animal Care Committee. Thioglycolate-elicited mouse peritoneal macrophages, 18 C/EBP␤-deficient macrophages, control macrophages (kind gifts from Valeria Poli, Department of Genetics, Biology, and Biochemistry, University of Turin, Turin, Italy), 35, 36 and RAW 264.7 macrophages (ATCC) were grown in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum, 50 U/mL penicillin, 50 g/mL streptomycin, and 1.5 mg/mL sodium bicarbonate in humidified atmosphere of 95% air and 5% CO 2 .
Preparation of heat-killed E coli
E coli strain K12 was grown in Luria Bertani (LB) medium overnight at 37°C with shaking at 220 rpm. Cells were centrifuged at 3000g for 15 minutes at 4°C and resuspended in phosphate-buffered saline at a density of 10 8 /mL. Thereafter, bacteria were heat-inactivated by incubation at 65°C for 90 minutes. The killed cells were collected by centrifugation at 3000g for 15 minutes at 4°C and resuspended in phosphate-buffered saline at a density of 6 ϫ 10 9 /mL. RNA extraction, cDNA synthesis, and real-time polymerase chain reaction Total RNA was prepared from macrophages and reverse-transcribed, as previously described. 32 For detection of IL-10 and TRAF6 mRNA, real-time polymerase chain reaction commercial kits (Applied Biosystems, Foster City, CA) were used, and all data were normalized to constitutive rRNA values. The Applied Biosystems 7700 sequence detector was used for amplification of target mRNA, and quantitation of differences between treatment groups was calculated according to the manufacturer's instructions.
Generation of C/EBP consensus mutant IL-10 promoter luciferase construct
The mutated IL-10 promoter was prepared by gene synthesis by GenScript (Piscataway, NJ). The following nucleotides were changed in the C/EBP consensus sequences of the 5Ј-flanking region of the IL-10 gene between Ϫ410/Ϫ390relativetothetranscriptionstart site: Ϫ410-TGGAGGAAACAATTA-TTTCTC-390, The mutated construct had the following sequence: Ϫ410 TGGActgtgCAATTAgtaCTC-390. The mutated DNA fragment was inserted into pGL2-Basic vector. The mutation sites were confirmed by DNA sequencing.
Transient transfection of RAW 264.7 cells with IL-10 promoter-luciferase constructs, C/EBP luciferase construct and A 2A receptor overexpressing construct, and luciferase assay RAW 264.7 cells were transiently transfected using FUGENE 6.0 transfection reagent (Roche, Indianapolis, IN). For transfection, 0.5 ϫ 10 6 /mL cells were plated in a 24-well plate. The next day, the cells were transfected with 0.4 g of IL-10 reporter plasmids (kind gifts from Stephen T. Smale, University of California, Los Angeles, School of Medicine, Los Angeles, CA), and an A 2A adenosine receptor overexpressing pA 2A -cytomegalovirus construct (Origene) or C/EBP reporter plasmid (Stratagene). All transfections were performed at 37°C overnight, after which procedure the cells were washed with Dulbecco modified Eagle medium and treated with heat-killed E coli and/or adenosine for 8 hours. For reporter assays, whole-cell extracts were prepared using 80 L 1 ϫ passive lysis buffer (Promega, Madison, WI). Luciferase activity was determined from 20 L cell extract.
Preparation of pSilencer plasmids with hairpin siRNA constructs and stable transfection
Specific hairpin siRNA (shRNA) oligonucleotide constructs for murine TRAF6 silencing were designed using the Ambion siRNA design algorithm, synthesized in the New Jersey Medical School Biotechnology Central facility, and cloned into the pSilencer3.1-H1neo expression vector (Ambion, Austin, TX), following the manufacturer's protocol. The shRNA constructs were designed targeting both the 5Ј end and the 3Ј of the gene. As controls, nonspecific shRNA with the same nucleotide composition as the specific inserts, but lacking significant homology with any sequence in the murine genome database, were also prepared. RAW 264.7 cells were transfected with shRNA-containing plasmids using Superfect transfection reagent (Qiagen, Valencia, CA), following the manufacturer's protocol. G418-resistant colonies were selected after approximately 2 weeks of growth. Six single clones of each shRNA transfection were selected and grown. G418 was maintained in the medium for the growth of the clones.
Nuclear protein extraction and C/EBP electrophoretic mobility shift assay RAW 264.7 cells were stimulated with adenosine and E coli for various periods and nuclear protein extracts were prepared as described previously. 37 The C/EBP consensus oligonucleotide probe used for electrophoretic mobility shift assay was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Electrophoretic mobility shift assays were performed as described previously for nuclear factor-B 37 or CREB. 38 For supershift studies, samples were preincubated with a C/EBP␤ or C/EBP␦ antibody (Santa Cruz Biotechnology).
Western blot analysis of C/EBP␤, C/EBP␦, phospho-p38, and phospho-p42/44 C/EBP␤ and C/EBP␦ protein levels were analyzed using 10 g of nuclear extracts using antibodies raised against C/EBP␤ and C/EBP␦, respectively. Western blotting to detect p38 and p42/44 phosphorylation was performed as we have described previously 38 using rabbit anti-phospho-p42/44 and monoclonal mouse anti-phospho-p38 (both from Cell Signaling, Danvers, MA).
IL-10 enzyme-linked immunosorbent assay
Peritoneal macrophages in 96-well plates (2 ϫ 10 5 /mL) were treated with adenosine or various adenosine receptor agonists, followed immediately by addition of E coli. IL-10 levels in cell supernatants were determined by enzyme-linked immunosorbent assay. 32 
Statistical analysis
Values in the figures are expressed as mean plus or minus the SEM of the indicated number of observations. Statistical analyses of the data were performed by Student t test or one-way analysis of variance followed by the Dunnett test, as appropriate.
Results
A 2A adenosine receptor activation and E coli synergistically induce IL-10 release by macrophages We have shown recently that genetic inactivation of A 2A receptors almost completely abolishes IL-10 production induced by a polymicrobial challenge in mice, suggesting that A 2A receptor activation is required for IL-10 production after bacterial stimuli. 32 To begin to examine the nature of the interaction of bacterial stimuli and A 2A receptor signaling in vitro, peritoneal macrophages were obtained from A 2A adenosine receptor KO and WT mice and treated with E coli and adenosine. Macrophages from A 2A receptor WT mice produced low levels of IL-10 after exposure to E coli but not adenosine ( Figure 1A) . Challenging E coli-treated WT cells with adenosine dramatically increased IL-10 levels ( Figure 1A ). However, neither adenosine ( Figure 1A ) nor E coli ( Figure 1A ) was capable of eliciting IL-10 release by A 2A KO mouse macrophages. Moreover, the combination of these 2 agents was also ineffective in triggering IL-10 release by A 2A KO macrophages ( Figure 1A ). We next treated macrophages with E coli in the presence or absence of various adenosine receptor agonists. Both the selective A 1 receptor agonist CCPA and A 3 receptor agonist IB-MECA failed to mimic the stimulatory effect of adenosine on IL-10 release. However, both the selective A 2A receptor agonist CGS21680 and nonselective agonist NECA increased IL-10 release by E coli-challenged macrophages, with CGS21680 being the most potent ( Figure 1B) .
We then investigated the role of A 2B receptors using A 2B receptor KO and WT mice, because previous studies have implicated A 2B receptors in regulating IL-10 release. 18, 22 E coli induced the release of IL-10 by macrophages from both A 2B WT and KO mice to the same extent. Adenosine enhanced substantially this E coli-induced IL-10 release in A 2B WT mice, which was slightly (approximately 10%) but consistently decreased in A 2B KO mice ( Figure 1C ).
Adenosine and E coli synergistically upregulate IL-10 release by a partially TLR4-independent mechanism
Recent studies have illustrated that bacteria contain a number of components that are able to elicit IL-10 secretion independently of LPS and TLR4. 39 To determine whether bacterial components that are not TLR4 ligands could be involved in the synergistic upregulation of IL-10 release after combined administration of receptor WT peritoneal macrophages. E coli both in the absence and presence of adenosine fails to induce IL-10 production by A2A KO macrophages. A2A KO and WT peritoneal macrophages were treated with heat-killed E coli (at a macrophage:bacterium ratio of 1:15) or cotreated with 100 M adenosine and heat-killed E coli for 5 hours, and then IL-10 was measured from the supernatant using enzyme-linked immunosorbent assay. ***P Ͻ .001 vs. E coli A2A WT group. (B) Effect of adenosine receptor agonists on IL-10 production. The agonists were added to macrophages before stimulating with E coli. IL-10 concentrations were measured from the supernatants taken 5 hours after E coli stimulation. ***P Ͻ .001 vs. vehicle. (C) E coli and adenosine synergize in inducing IL-10 production by A 2B receptor WT and, to a lesser extent, A2B KO peritoneal macrophages. A2B KO and WT peritoneal macrophages were treated with heat-killed E coli or cotreated with 100 M adenosine and heat-killed E coli for 5 hours, and then IL-10 was measured from the supernatant using enzyme-linked immunosorbent assay. **P Ͻ .01 vs. E coli A 2B WT group. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 6 in each experiment.
BLOOD, 1 OCTOBER 2007 ⅐ VOLUME 110, NUMBER 7 For personal use only. on April 4, 2017. by guest www.bloodjournal.org From E coli and adenosine, we treated peritoneal macrophages obtained from TLR4 KO and WT mice with adenosine and heat-killed E coli. We found that E coli was capable of inducing low levels of IL-10 in TLR4 WT macrophages, which was decreased in TLR4 KO cells (Figure 2A ). Exogenous adenosine synergistically upregulated (Ͼ 10-fold) E coli-induced IL-10 release in TLR4 WT cells. Although the combined exposure of adenosine and E coli induced lower levels of IL-10 in TLR4 KO macrophages than the same treatment in TLR4 WT cells, adenosine upregulated E coli induced IL-10 release to the same degree (Ͼ 10-fold) in TLR4 WT and TLR4 KO cells ( Figure 2A ). We next examined whether adenosine affected the release of IL-6, a pro-inflammatory cytokine, independently of TLR4. E coli triggered IL-6 release in TLR4 WT and to a lesser extent in TLR4 KO macrophages, and adenosine decreased this IL-6 release in both WT and KO cells approximately to the same degree (by approximately 30%; Figure 2B ).
To confirm that adenosine can upregulate bacteria-induced IL-10 release independently of TLR4, we challenged peritoneal macrophages with heat-killed S aureus, a Gram-positive bacterium, which, unlike Gram-negative E coli, is thought to act in a TLR4-independent fashion to elicit macrophage activation. We observed that S aureus increased IL-10 levels, which were further enhanced by adenosine ( Figure 2C ). We then investigated the effect of adenosine on IL-10 release that was induced by the specific TLR2 agonist lipoteichoic acid prepared from S aureus. This TLR2 agonist elicited the release of IL-10 by macrophages, and adenosine boosted the TLR2 agonist-induced IL-10 level ( Figure 2D ).
Collectively, our results demonstrate that E coli increases IL-10 release in macrophages, and this effect is partially dependent on TLR4. Moreover, adenosine upregulates bacteria-induced IL-10 secretion and down-regulates IL-6 release by a mechanism that does not require TLR4.
E coli-induced and adenosine-induced IL-10 release is MyD88-independent
MyD88 has been documented to contribute to intracellular signaling from all TLRs except TLR3. In addition, recent evidence indicates that TLR signaling consists of both MyD88-dependent and a MyD88-independent pathways. 40 Because of the central role of MyD88 in many bacteria-induced macrophage responses, 41, 42 we first studied whether MyD88 regulated IL-10 release in macrophages challenged with E coli, adenosine, or the combination of E coli and adenosine. There was no difference in IL-10 release by peritoneal macrophages obtained from MyD88 WT and KO mice after E coli treatment and the IL-10 level was upregulated to the same degree in WT and KO macrophages after adenosine treatment ( Figure 3A) .
Previous work has shown that in the absence of MyD88 the production of IL-6 is decreased or completely abolished depending on which TLR activates IL-6 gene expression. 34, 42 In addition, Effects of E coli and adenosine on IL-10 and IL-6 production by TLR4 WT and KO macrophages. (A) Adenosine synergizes with heat-killed E coli to up-regulate IL-10 production in both TLR4 WT and KO macrophages. Peritoneal macrophages were obtained from TLR4 KO and WT mice and were treated with heat-killed E coli (at a macrophage:bacterium ratio of 1:15) or E coli plus 100 M adenosine for 5 hours, after which procedure IL-10 production was determined from the supernatant. ***P Ͻ .001 vs. corresponding E colitreated group. ### P Ͻ .001 vs. corresponding E coli-treated groups. ## P Ͻ .01 vs. TLR4 WT group. (B) Effect of adenosine and E coli on IL-6 production. IL-6 levels were determined from the same supernatant that was used for measuring IL-10 production. ### P Ͻ .001 vs. corresponding TLR4 WT groups, **P Ͻ .01 vs. E coli-stimulated group. (C) S aureus (at a macrophage:bacterium ratio of 1:15) stimulates IL-10 levels, which is enhanced by adenosine. The enhancing effect of adenosine on S aureus-stimulated IL-10 production is reversed by the A2A receptor antagonist ZM241385. Peritoneal macrophages were obtained from CD-1 mice. IL-10 production was measured after 5 hours of stimulation with S aureus and/or 100 M adenosine. ***P Ͻ .001 vs. S aureus alone. ### P Ͻ .001 vs. 100 M adenosine. (D) Lipoteichoic acid prepared from S aureus stimulates IL-10 release by CD-1 mouse peritoneal macrophages, which is enhanced by adenosine. Peritoneal macrophages were obtained from CD-1 mice and treated with 1 g/mL lipoteichoic acid prepared from S aureus or lipoteichoic acid prepared from S aureus plus 100 M adenosine for 5 hours, after which IL-10 release was determined from the supernatant. *P Ͻ .05 vs. control and ***P Ͻ .001 vs. control. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 6 in each experiment. Figure 3 . Role of MyD88 in regulating IL-10 and IL-6 production by E coli-treated and adenosine-stimulated macrophages. (A) MyD88 is not necessary for the synergistic effect of adenosine and E coli on IL-10 production. Peritoneal macrophages were taken from MyD88 KO and WT mice. After 5 hours of stimulation with heat-killed E coli or E coli plus adenosine IL-10 enzyme-linked immunosorbent assay was performed. ***P Ͻ .001 vs. corresponding adenosine-untreated, E coli-stimulated groups. (B) MyD88 is partially required for E coli-induced IL-6 production. IL-6 cytokine levels were determined from the same supernatants that were used for IL-10 detection. ### P Ͻ .001 vs. E coli-treated MyD88 WT group, ## P Ͻ .01 vs. adenosine/E coli-treated MyD88 WT group. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 6 in each experiment.
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contrary to its stimulatory effect on IL-10 production, adenosine has been shown to suppress IL-6 production by TLR4-stimulated macrophages. 43 IL-6 release in E coli-stimulated MyD88 KO macrophages was decreased compared with WT macrophages, and adenosine decreased the IL-6 level in both MyD88 KO and WT peritoneal macrophages ( Figure 3B ). These results indicate that the release of the anti-inflammatory cytokine IL-10 and pro-inflammatory IL-6 were regulated differentially by adenosine, and that while IL-10 release is completely MyD88-independent, IL-6 release is partially MyD88-dependent.
TRAF6 negatively impacts the effect of E coli and adenosine on IL-10 release TRAF6 has been shown to be a crucial intracellular protein for the induction of pro-inflammatory genes in macrophages in response to bacteria or TLR agonists. [44] [45] [46] Therefore, we assessed using an shRNA approach whether TRAF6 would be required for the effect of E coli and/or adenosine also on IL-10 release. First, we confirmed that TRAF6 shRNA-expressing cells expressed 83% less TRAF6 mRNA than cells stably transfected with a control vector expressing scrambled TRAF6 sequences ( Figure 4A ). Then, we treated cells with heat-killed E coli and/or adenosine and measured cytokine levels. In agreement with previous data, 44 release by E coli-induced macrophages was decreased in TRAF6 shRNA-expressing cells compared with controls (scrambled shRNA-expressing cells; Figure 4B ), indicating that IL-6 release after inflammatory stimuli requires TRAF6. Moreover, adenosine decreased IL-6 release in control cells, but did not reduce it in TRAF6 shRNA-expressing cells ( Figure 4B ), indicating that the suppressive effect of adenosine was TRAF6-dependent. In contrast, IL-10 levels were markedly higher in TRAF6 shRNAexpressing cells than in control cells after both E coli and E coli/adenosine treatment ( Figure 4C ). The fact that adenosine was less efficacious in potentiating the stimulatory effect of E coli on IL-10 release in RAW 264.7 cells (Figure 4 ) than in peritoneal macrophages (Figures 1-3) is probably a reflection of the low expression of A 2A receptors on RAW cells. 37 In sum, these findings indicate that TRAF6 is not required for the effect of E coli and adenosine in inducing IL-10, but TRAF6 negatively modulates this synergistic interaction.
The stimulatory effect of adenosine on E coli-induced IL-10 release is associated with increased IL-10 mRNA accumulation and promoter activity
To investigate the mechanisms that are responsible for the increased release of IL-10 by bacteria-activated macrophages both in the absence and presence of adenosine, we determined IL-10 mRNA levels from CD-1 peritoneal macrophages using real-time polymerase chain reaction. We found that E coli increased IL-10 mRNA levels by approximately 4-fold, and adenosine further augmented by approximately 8-fold the E coli-induced accumulation of IL-10 mRNA ( Figure 5A ). In addition, adenosine had no effect on IL-10 mRNA levels in the absence of E coli ( Figure 5A ). The transcriptional inhibitor actinomycin D prevented the synergistic effect of E coli and adenosine in inducing IL-10 mRNA and protein accumulation arguing for the transcriptional nature of this synergism ( Figure 5A,B) .
We also studied the effect of adenosine on E coli-induced IL-10 promoter activity by transfecting RAW 264.7 cells with a construct in which luciferase expression was driven by the full-length IL-10 promoter. 11 We found that E coli increased IL-10 promoter activity, and adenosine enhanced IL-10 promoter activity approximately 2-fold in E coli-induced but not control macrophages that were not exposed to E coli ( Figure 5C ). Because RAW 264.7 macrophages express low levels of the A 2A receptor endogenously, 37 we transfected these cells with an A 2A receptor-expressing construct ( Figure  5C ). This enforced expression of the A 2A receptor resulted in a more pronounced increase in IL-10 promoter activity both after E coli and the combination of E coli plus adenosine, underscoring the importance of A 2A receptors in augmenting IL-10 production.
The sequence encompassing ؊438 to ؊376 of the 5 flanking region of the IL-10 gene is required for the stimulatory effect of adenosine on E coli-induced IL-10 promoter activity
To identify the DNA sequences that are necessary for adenosine to increase IL-10 promoter activity in E coli-challenged cells, a series .7 macrophages stably transfected with TRAF6 shRNA compared with scrambled shRNA. TRAF6 mRNA level was measured using real-time reverse-transcription polymerase chain reaction using total RNA isolated from untransfected, scrambled shRNA-transfected and TRAF6 shRNA-transfected RAW 264.7 macrophages. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 4 in each experiment. ### P Ͻ .001. (B) IL-6 production was decreased by TRAF6 gene silencing and the suppressive effect of adenosine is TRAF6-dependent in E coli-stimulated macrophages. RAW 264.7 cells were transfected with a plasmid generating TRAF6 shRNAs for silencing of TRAF6. The transfected macrophages were treated with heat-killed E coli or E coli plus 100 M adenosine for 5 hours, and IL-6 levels were measured using enzyme-linked immunosorbent assay from the supernatants taken at the end of the incubation period. ### P Ͻ .001 vs. scrambled. (C) Effect of TRAF6 silencing on IL-10 production by macrophages exposed to E coli or E coli plus adenosine. IL-10 production was determined from the supernatants that were obtained from stably transfected RAW 264.7 cells after 5 hours of exposure to E coli or E coli plus adenosine. *P Ͻ .05 vs. scrambled. ***P Ͻ .001 vs. scrambled. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 4 in each experiment.
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For personal use only. on April 4, 2017. by guest www.bloodjournal.org From of promoter mutants that contain successive deletions from the 5Ј end were inserted upstream of the luciferase reporter gene 11 ( Figure  5D ). After transfection of RAW 264.7 cells with these constructs, luciferase activity was detected after adenosine/E coli treatment. Analysis of luciferase activity from the 5Ј deletion mutants revealed that deletion of sequences between Ϫ1538 and Ϫ438 from the transcription start site did not affect the effect of adenosine in stimulating promoter activity. In contrast, the effect of adenosine was completely abolished by deletion of sequences between Ϫ438 and Ϫ376 ( Figure 5D ). These results show that DNA sequences in the IL-10 promoter between Ϫ438 and Ϫ376 are sufficient for the enhancing effect of adenosine on IL-10 promoter activity in E coli-treated macrophages. Using Searching Transcription Factor Binding Sites program we found that there were 2 potential binding sites for C/EBP (Ϫ410/Ϫ399 and Ϫ398/Ϫ385) in this promoter region.
To confirm that these 2 potential C/EBP binding sites are necessary for the stimulatory effect of adenosine on IL-10 promoter activity, we mutated these sites and this modified sequence was inserted upstream of the luciferase reporter gene into pGL2. Analysis of luciferase activity from this construct revealed that mutating the C/EBP consensus sites prevented the stimulatory effect of adenosine on E coli-induced promoter activity ( Figure 5E ).
C/EBP␤ is required for the stimulatory effect of adenosine on IL-10 release by E coli-challenged macrophages
Because the IL-10 promoter sequence between Ϫ438 and Ϫ376 contains binding sites for C/EBP transcription factors, we first determined the effect of E coli as well as E coli plus adenosine on C/EBP transcriptional activity. To this end, RAW 264.7 macrophages were transfected with a construct in which luciferase expression is driven by C/EBP. The transfected cells were treated with adenosine and E. coli, and luciferase activity was measured after 8 hours of treatment. We found that E coli stimulated C/EBP luciferase activity by approximately 2-fold and adenosine upregulated this activity by another approximately 2-and-one-half-fold ( Figure 6A ). Adenosine alone had no effect on C/EBP luciferase activity ( Figure 6A ). We then determined the effect of E coli and adenosine on C/EBP DNA binding. Using nuclear extracts from E coli-stimulated macrophages, we observed a significant increase in protein binding to a C/EBP consensus sequence at 30 and 60 minutes compared with untreated cells, and adenosine further enhanced this induction of C/EBP DNA binding ( Figure 6B ). In competition binding 
0 xc o l dp r o b e relative density IL-10 (pg/mL) absolute luciferase activity relative density Figure 6 . Adenosine enhances C/EBP␤ activation in E coli-stimulated macrophages. (A) Adenosine up-regulates C/EBP-luciferase activity in macrophages exposed to E coli. RAW 264.7 macrophages were transfected with a luciferase reporter vector driven by C/EBP (pC/EBP-luc) or a control vector (pCIS-CK). Cells were treated with E coli and adenosine (100 M) for 8 hours, after which period the cells were lysed and luciferase activity determined. Luciferase reporter activities were normalized to protein concentration. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 3 in each experiment. *P Ͻ .05 and **P Ͻ .01 vs. control. (B) Adenosine enhances E coli-induced C/EBP␤ DNA binding. RAW cells were treated with heat-killed E coli or simultaneously with 100 M adenosine and heat-killed E. coli, and nuclear proteins were extracted at 30, 60, and 90 minutes thereafter. C/EBP␤ DNA binding of nuclear proteins was measured using electrophoretic mobility shift assay. The upper panel shows densitometric analysis of intensities of complexes (fold increase vs. control) observed on the gel (lower panel). (C) An antibody against C/EBP␤ shifts the adenosine/E coli-induced (for 60 minutes) DNA-protein complex. For supershift studies nuclear extracts were preincubated with C/EBP␤ and C/EBP␦ antibodies before the binding reaction, and the complexes were separated by electrophoretic mobility shift assay and visualized using autoradiography. The figure shown is representative of 3 separate experiments. (Di) Adenosine increases E coli-induced C/EBP␤ protein accumulation in the nuclear fraction of RAW 264.7 cells. Cytosolic and nuclear protein extracts were taken at 30 and 60 minutes after exposure to E coli or E coli plus adenosine (100 M) and C/EBP␤ expression was determined by Western blotting and autoradiography. (E) Densitometric analysis of the 3 C/EBP␤ isoforms detected by autoradiography on the blot shown in (Di; fold increase vs. control). The figure is representative of 3 separate experiments. (F) E coli both in the absence and presence of adenosine fails to increase IL-10 production by C/EBP␤-deficient macrophages. C/EBP␤ WT and KO macrophages were challenged with E coli or E coli plus adenosine and IL-10 production was determined from the supernatants after a 5-hour stimulation. Results (mean Ϯ SEM) shown are representative of at least 3 experiments with n ϭ 6 in each experiment. ***P Ͻ .001 vs. E coli.
For personal use only. on April 4, 2017. by guest www.bloodjournal.org From assay, a 50-fold molar excess of cold C/EBP consensus probe completely abrogated the binding of the radiolabeled C/EBP probe ( Figure  6B ). The C/EBP family contains several members and within this family C/EBP␤ and C/EBP␦ are both expressed in macrophages. 47 Therefore, we determined the nature of the different C/EBP isoforms binding to the C/EBP consensus oligo using antibodies specific for C/EBP␤ or ␦ in supershift studies using nuclear extracts from E coli/adenosine-treated RAW 264.7 macrophages. Figure 6C shows that only the C/EBP␤ antibody shifted the DNA-protein complex. To obtain additional evidence for the role of C/EBP, we performed immunodetection of C/EBP␤ and C/EBP␦ from nuclear and cytosolic fractions of macrophages after adenosine and/or E coli treatment using antibodies raised against C/EBP␤ and C/EBP␦. This analysis revealed that C/EBP␦ did not accumulate in the nuclear fraction after either E coli or adenosine treatment (data not shown). However, 3 C/EBP␤ isoforms corresponding to the previously described 31, 48, 49 liver-enriched inhibitory protein, liver-enriched activating protein and full-length liver-enriched activating protein accumulated in nuclear fractions obtained from E colistimulated macrophages ( Figure 6D,E) . Furthermore, adenosine enhanced the nuclear accumulation of all 3 isoforms in the presence but not absence of E coli ( Figure 6D,E) . To provide further insight into the role of C/EBP␤ in regulating IL-10 production, C/EBP␤ WT and KO immortalized macrophage cell lines 31 were stimulated with heat-killed E coli and adenosine for 5 hours, and IL-10 release was measured by enzyme-linked immunosorbent assay. We found that E coli or the combination of E coli and adenosine failed to induce IL-10 release by C/EBP␤ KO cells, whereas these stimuli efficiently triggered IL-10 production by C/EBP␤ WT macrophages ( Figure 6F ). These data identify C/EBP␤ as the major transcription factor mediating the stimulatory effect of adenosine on IL-10 release in E coli-challenged cells.
p38 MAPK activation is required for the synergistic effect of adenosine and E coli on IL-10 release
Both TLR ligands and adenosine have been reported to be able to activate both p38 and p42/44 in macrophages. 38, 50, 51 Both p38 and p42/44 have been implicated in the regulation of IL-10 production in response to various TLR ligands. 52 ,53 Therefore, we tested the possibility that either p38 or p42/44 MAPK was involved in mediating the stimulatory effect of E coli or the combination of E coli and adenosine on IL-10 release. We first examined whether E coli or the combination of E coli and adenosine triggered the activation of p38 and p42/44 MAPKs. The results of these experiments showed that E coli increased p42/44 MAPK activation ( Figure 7A ) but not that of p38 ( Figure 7B ). When macrophages were treated with E coli and adenosine together, p38 activation was increased ( Figure 7B ), but the activation of p42/44 was not changed ( Figure 7A ), compared with E coli treatment alone. To examine whether this activation of p38 caused by adenosine contributed to the stimulatory effect of adenosine on E coliinduced IL-10 release, we investigated whether MAPK inhibition decreased the adenosine-stimulated IL-10 cytokine level. Treatment of peritoneal macrophages with the selective p38 MAPK pathway inhibitor SB203580 but not p42/44 MAPK inhibitor PD98059 completely abolished the IL-10 response to adenosine ( Figure 7C ).
Discussion
The most striking finding of this work is that endogenous adenosine acting at A 2A receptors represents a crucial second signal in inducing the production of IL-10. In addition, our results unequivocally demonstrate that C/EBP␤ is a central intracellular mediator on which signals from both E coli and adenosine receptors converge to induce IL-10 gene expression.
As we and others demonstrated, the most potent antiinflammatory effects of adenosine are mediated by A 2A or A 2B receptor stimulation on monocytes/macrophages, 18,54 lymphocytes, 55, 56 neutrophils, 57,58 dendritic cells, 59 and endothelial cells. 22, 60 However, the majority of these studies on the immunomodulatory effects of adenosine were confined to investigating TLR4-agonist (LPS)-induced inflammation. Ramakers et al 39 have recently shown that the modulatory effects of adenosine receptor stimulation on cytokine production critically depend on Recent data have shown that IL-10 production by macrophages was induced via TLR-mediated MyD88-dependent or TRIF-dependent pathways, as well as via non-TLR signals. 63 For example, LPS induction of IL-10 via TLR4 was dependent on MyD88 and TRIF. Triggering through TLR9 by CpG showed that the induction of high levels of IL-10 was completely MyD88-dependent in macrophages. Unlike with LPS and CpG, our results clearly indicate that IL-10 production in E colistimulated or E coli/adenosine stimulated macrophages is completely MyD88-independent. Because of the complexity of E coli, it is unclear at this juncture what E coli components trigger IL-10 production by macrophages. It is interesting to note that a nucleotide-binding oligomerization domain 2 ligand had synergistic effect on the induction of IL-10 on costimulation with a TLR agonist, 64 indicating that nucleotide-binding oligomerization domain 2, a TLR-independent protein, may have also contributed to the effect of E coli. It is also worth noting that because S aureus also elicited IL-10 secretion ( Figure 2C ), ligands common to both Gram-negative and Gram-positive bacteria, such as peptidoglycan and muramyl dipeptide, may have had a role in triggering IL-10 production. However, because adenosine synergistically augmented IL-10 release induced by lipoteichoic acid prepared from S aureus, a true TLR2 agonist, it is also possible that the adenosine-S aureus interaction was mediated by the specific Gram-positive bacterial product lipoteichoic acid prepared from S aureus.
We have shown recently that adenosine through A 2B receptors enhanced LPS-induced IL-10 production, and this effect was posttranscriptional, because adenosine had no effect either on LPS-induced IL-10 mRNA accumulation or on IL-10 promoter activity. 18 In contrast, our current results indicate that the mechanism of action of adenosine in upregulating IL-10 production by E coli-treated macrophages is transcriptional. Specifically, adenosine increased E coli-induced IL-10 mRNA accumulation and upregulated IL-10 promoter activity, and the effect of adenosine was blocked by actinomycin D. Our data have clearly demonstrated that C/EBP␤ is critical for the stimulatory effect of adenosine on IL-10 production in E coli-treated murine macrophages. First, sequential deletion analysis of the IL-10 promoter as well as site-directed mutagenesis showed that a region containing C/EBP␤ binding elements was responsible for the potentiating effect of adenosine in stimulating IL-10 promoter activity. Second, adenosine stimulated E coli-induced nuclear accumulation and DNA binding of C/EBP␤. Third, C/EBP␤-deficient macrophages failed to produce IL-10 in response to adenosine and E coli. Interestingly, C/EBP␤ was also important for the stimulatory effect E coli even in the absence of exogenous adenosine, because C/EBP␤-deficient macrophages failed to respond to E coli alone, and E coli alone induced increases in the nuclear levels and DNA binding of C/EBP␤.
From studies performed with different cell types a number of different transcriptional, translational and posttranslational mechanisms have been proposed to regulate C/EBP␤ activity. The most frequently reported mechanism is the increased induction of C/EBP␤ gene transcription. 65, 66 Regulation by nuclear translocation 67 and alternative translation initiation, 68 phosphorylation, 69 and acetylation 49, 70 have also been described. Our data suggest that C/EBP␤ activity is not regulated by nuclear translocation, because C/EBP␤ was undetectable in cytoplasmic fractions both before and after adenosine and/or E coli treatment.
The fact that adenosine alone, unlike E coli, was not able to induce IL-10 production, mRNA accumulation, and C/EBP␤ activation suggests that adenosine and E coli act by different mechanisms on the C/EBP␤ transcription factor system. Previous studies demonstrated that C/EBP␤ promoter activity is induced during monocyte activation, and binding of CREB to C/EBP␤ promoter elements is critical for the activation of C/EBP␤ transcription. 71 Moreover, we have recently found that adenosine enhances CREB transcriptional activity in macrophages. 38 Thus, it is plausible that adenosine up-regulates E coli-induced C/EBP␤ accumulation via CREB activation. This explanation is supported by our findings that adenosine stimulates both CREB activation 38 and IL-10 production ( Figure  7C ,D) in a p38-dependent manner. The fact that in contrast to the slow (4 hours) accumulation of C/EBP␤ in response to LPS reported previously, 72 we observed a rapid (30 minutes) increase in C/EBP␤ abundance after E coli exposure of macrophages suggests that the mechanism by which E coli activates C/EBP␤ is fundamentally different from not only that of adenosine but also that of LPS. Because adenosine can stimulate the activation of CREB 38 but not C/EBP␤ in the absence E coli, it is plausible that this CREB activation by exogenous or endogenous adenosine plays a permissive role in activating C/EBP␤ in response to E. coli. Further studies are warranted to investigate the mechanisms by which E coli and adenosine activate the C/EBP␤ system. In summary, we propose that A 2A receptor activation provides a crucial permissive and synergistic signal for IL-10 production in response to infectious agents. 
